História e próximos passos da Hemobrás – Futuro Explica

Brazil has depended for decades on medications produced from human plasma to treat patients with hemophilia, immunodeficiencies, and other serious diseases. Because global production is concentrated in a few manufacturers, ensuring the supply of these products is a challenge for the Brazilian public health system (SUS). It is in this context that Hemobrás emerges. The new episode of Futuro Explica tells the story of the state-owned company and its role in the production of blood products. Watch the full episode now! -- Also visit: https://futurodasaude.com.br/   / futurodasaude   #FuturodaSaude #FuturoExplica #Hemobrás #hemoderivados